248 related articles for article (PubMed ID: 7522372)
1. Mapping of antigenic domains in poliovirus VP1 involved in structural rearrangements during virus morphogenesis and antigenic alterations of the virion.
Ketterlinus R; Wiegers K
Virology; 1994 Oct; 204(1):27-37. PubMed ID: 7522372
[TBL] [Abstract][Full Text] [Related]
2. Controlled conformational transitions in the MVM virion expose the VP1 N-terminus and viral genome without particle disassembly.
Cotmore SF; D'abramo AM; Ticknor CM; Tattersall P
Virology; 1999 Feb; 254(1):169-81. PubMed ID: 9927584
[TBL] [Abstract][Full Text] [Related]
3. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein.
Gedvilaite A; Frömmel C; Sasnauskas K; Micheel B; Ozel M; Behrsing O; Staniulis J; Jandrig B; Scherneck S; Ulrich R
Virology; 2000 Jul; 273(1):21-35. PubMed ID: 10891404
[TBL] [Abstract][Full Text] [Related]
4. The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1.
Bruneau P; van der Werf S; Wychowski C; Siffert O; Girard M
Dev Biol Stand; 1984; 57():177-85. PubMed ID: 6084609
[TBL] [Abstract][Full Text] [Related]
5. Topology of the major capsid protein P3 of bacteriophage PRD1: analysis using monoclonal antibodies and C-terminally truncated proteins.
Bamford JK; Luo C; Juuti JT; Olkkonen VM; Bamford DH
Virology; 1993 Dec; 197(2):652-8. PubMed ID: 7504366
[TBL] [Abstract][Full Text] [Related]
6. [A model of the secondary structure and distribution of antigenic determinants in the VP1 protein of hepatitis A virus].
Mesianzhinov VV
Biofizika; 1986; 31(6):961-3. PubMed ID: 2432945
[TBL] [Abstract][Full Text] [Related]
7. Conformational flexibility in a highly mobile protein loop of foot-and-mouth disease virus: distinct structural requirements for integrin and antibody binding.
Feliu JX; Benito A; Oliva B; Avilés FX; Villaverde A
J Mol Biol; 1998 Oct; 283(2):331-8. PubMed ID: 9769208
[TBL] [Abstract][Full Text] [Related]
8. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
Gromowski GD; Barrett AD
Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
[TBL] [Abstract][Full Text] [Related]
9. Antigenic mapping of the recombinant Norwalk virus capsid protein using monoclonal antibodies.
Hardy ME; Tanaka TN; Kitamoto N; White LJ; Ball JM; Jiang X; Estes MK
Virology; 1996 Mar; 217(1):252-61. PubMed ID: 8599210
[TBL] [Abstract][Full Text] [Related]
10. Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus.
Parry N; Fox G; Rowlands D; Brown F; Fry E; Acharya R; Logan D; Stuart D
Nature; 1990 Oct; 347(6293):569-72. PubMed ID: 1699132
[TBL] [Abstract][Full Text] [Related]
11. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice.
Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L
Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698
[TBL] [Abstract][Full Text] [Related]
12. Epitope structures recognised by antibodies against the major coat protein (g8p) of filamentous bacteriophage fd (Inoviridae).
Kneissel S; Queitsch I; Petersen G; Behrsing O; Micheel B; Dübel S
J Mol Biol; 1999 Apr; 288(1):21-8. PubMed ID: 10329123
[TBL] [Abstract][Full Text] [Related]
13. Conformational preferences of a peptide corresponding to the major antigenic determinant of foot-and-mouth disease virus: implications for peptide-vaccine approaches.
de Prat-Gay G
Arch Biochem Biophys; 1997 May; 341(2):360-9. PubMed ID: 9169027
[TBL] [Abstract][Full Text] [Related]
14. Topology of bovine rotavirus (RF strain) VP6 epitopes by real-time biospecific interaction analysis.
Tosser G; Delaunay T; Kohli E; Grosclaude J; Pothier P; Cohen J
Virology; 1994 Oct; 204(1):8-16. PubMed ID: 7522377
[TBL] [Abstract][Full Text] [Related]
15. Antigenic analysis of poliovirus type 3 using monoclonal antibodies.
Ferguson M; Minor PD; Magrath DI; Schild GC
Dev Biol Stand; 1984; 57():151-5. PubMed ID: 6098495
[TBL] [Abstract][Full Text] [Related]
16. Mutations in the poliovirus P1 capsid precursor at arginine residues VP4-ARG34, VP3-ARG223, and VP1-ARG129 affect virus assembly and encapsidation of genomic RNA.
Ansardi DC; Luo M; Morrow CD
Virology; 1994 Feb; 199(1):20-34. PubMed ID: 8116243
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak.
Shaw J; Jorba J; Zhao K; Iber J; Chen Q; Adu F; Adeniji A; Bukbuk D; Baba M; Henderson E; Dybdahl-Sissoko N; McDonald S; Weldon WC; Gumede N; Oberste MS; Kew OM; Burns CC
J Virol; 2018 May; 92(9):. PubMed ID: 29444940
[TBL] [Abstract][Full Text] [Related]
18. Neutralization epitopes on poliovirus type 3 particles: an analysis using monoclonal antibodies.
Ferguson M; Minor PD; Magrath DI; Qui YH; Spitz M; Schild GC
J Gen Virol; 1984 Jan; 65 ( Pt 1)():197-201. PubMed ID: 6198447
[TBL] [Abstract][Full Text] [Related]
19. Antigenic sites on the receptor-binding domain of human adenovirus type 2 fiber.
Fender P; Kidd AH; Brebant R; Oberg M; Drouet E; Chroboczek J
Virology; 1995 Dec; 214(1):110-7. PubMed ID: 8525605
[TBL] [Abstract][Full Text] [Related]
20. Application of monoclonal antibodies for the identification of the antigenic site for poliovirus neutralization.
Minor PD; Schild GC; Evans D; Ferguson M; Almond J
Dev Biol Stand; 1984; 57():171-5. PubMed ID: 6084608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
